Last edition
News about "RNA therapeutics"
Hongene Biotech Supports SiranBio's Dual-Target siRNA Programme for Chronic Hepatitis B
Hongene Biotech provided end-to-end CDMO support for SiranBio’s SA1211 siRNA candidate, highlighting its capabilities in complex oligonucleotide therapeutic development and manufacturing.
RNA Therapeutics | 11/05/2026 | By News Bureau
Novartis agrees to acquire Avidity Biosciences
Novartis has announced a definitive agreement to acquire Avidity Biosciences, a move aimed at expanding its neuroscience portfolio with advanced programs targeting rare genetic neuromuscular disorders.
RNA Therapeutics | 27/10/2025 | By Dineshwori | 265
Avidity Biosciences Welcomes Simona Skerjanec to its Board of Directors
Avidity Biosciences, Inc. has strengthened its leadership with the appointment of Simona Skerjanec, M.Pharm, MBA to its board of directors.
RNA Therapeutics | 16/05/2024 | By Aishwarya | 237
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy